Last $234.86 USD
Change Today -0.94 / -0.40%
Volume 1.9M
As of 4:15 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - allergan inc (AGN)

Name (Connections)Board RelationshipsTitleKey Developments
Russell Ray 50 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Organization & Compensation Committee 
Louis Lavigne Jr. 80 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Science & Technology Committee 
Deborah Dunsire M.D. 161 RelationshipsIndependent Director, Member of Science & Technology Committee and Member of Audit & Finance Committee 
Timothy Proctor 8 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Organization & Compensation Committee 

Compensation Committee* - allergan inc (AGN)

Name (Connections)Board RelationshipsTitle
Michael Gallagher 8 RelationshipsLead Independent Director, Chairman of Organization & Compensation Committee and Member of Corporate Governance & Compliance Committee
Timothy Proctor 8 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Organization & Compensation Committee
Russell Ray 50 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Organization & Compensation Committee
AGN Compensation vs. Industry
1.4M
384.5K
Chief Executive Officer
425.5K
257.8K
Chief Financial Officer
Share price activity for ALLERGAN INC (AGN)
52 Week Price Performance
AGN
Industry Average

Corporate Governance Committee* - allergan inc (AGN)

Name (Connections)Board RelationshipsTitle
Michael Gallagher 8 RelationshipsLead Independent Director, Chairman of Organization & Compensation Committee and Member of Corporate Governance & Compliance Committee
Trevor Jones CBE, Ph.D., DSc FKC FPS FRSC Hon FRCP FBPharmcolS 64 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Organization & Compensation Committee
Peter McDonnell M.D. 14 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Organization & Compensation Committee
AGN and Competitor
Insiders vs. External
Board
11%
89%
Allergan Inc.
25%
75%
Regeneron Pharmaceuticals, Inc.
14%
86%
Actavis plc
23%
77%
Mylan, Inc.
17%
83%
Boston Scientific Corporation
18%
82%
Astellas Pharma, Inc.
Insiders
External Board Members

Finance Committee* - allergan inc (AGN)

Name(Connections)Board RelationshipsTitle
Deborah Dunsire M.D. 161 RelationshipsIndependent Director, Member of Science & Technology Committee and Member of Audit & Finance Committee
Louis Lavigne Jr. 80 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Science & Technology Committee
Timothy Proctor 8 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Organization & Compensation Committee
Russell Ray 50 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Organization & Compensation Committee
Debt To Total Capitalization21.7x
It is important for the finance committee to know when to issue debt or equity.

Management/Organization Development Committee* - allergan inc (AGN)

Name(Connections)Board RelationshipsTitle
Michael Gallagher 8 RelationshipsLead Independent Director, Chairman of Organization & Compensation Committee and Member of Corporate Governance & Compliance Committee
Timothy Proctor 8 RelationshipsIndependent Director, Member of Audit & Finance Committee and Member of Organization & Compensation Committee
Russell Ray 50 RelationshipsIndependent Director, Chairman of Audit & Finance Committee and Member of Organization & Compensation Committee
Rank Against Competitors
Revenue/Employee
$688.2K47
Earnings/Employee
$217.7K90
K = Thousand
M = Million
B = Billion
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $234.86 USD -0.94

AGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $296.23 USD -1.08
Astellas Pharma Inc ¥1,977 JPY +27.00
Boston Scientific Corp $16.76 USD -0.30
Mylan NV $55.44 USD -2.45
Regeneron Pharmaceuticals Inc $412.51 USD -5.93
View Industry Companies
 

Industry Analysis

AGN

Industry Average

Valuation AGN Industry Range
Price/Earnings 46.3x
Price/Sales 9.6x
Price/Book 9.0x
Price/Cash Flow 42.7x
TEV/Sales 8.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.